Morningstar2h
A Practical Test for Contrarian Investing: When Should You Go Against the Grain?
We like funds with great long-term performance, but if short-term returns get red hot, we get a little wary. As you may ...
3 Great Contrarian ETFs
Investing rewards are a different story. Some of the best investors are contrarians that uncover value by zigging while the ...
The Election Is One More Headache for Clean Energy ETFs
The largest clean energy ETF, the $1.7 billion iShares Global Clean Energy ETF ICLN, has lost 11% since Election Day, while ...
Hanesbrands’ Actions Are Supporting Its Category-Leading Innerwear Brands and Financial Health
Hanesbrands is the market leader in basic innerwear in multiple countries. We believe its key innerwear brands, like Hanes and Bonds in Australia, achieve premium pricing. Our narrow moat rating on ...
Jacobs Is Poised to Capitalize on Favorable Secular Trends in Infrastructure
Furthermore, Jacobs’ portfolio is well-aligned with multiple favorable secular trends, including growing investment in infrastructure as well as the transition to clean energy. We believe that Jacobs ...
WEC Energy Group: Wisconsin Rate Outcome Key Positive Signal
Nearly 75% of WEC's earnings come from areas with what we view as constructive regulation, such as Wisconsin and at the Federal Energy Regulatory Commission. Its commercial renewable energy business ...
COVID-19 virus may have a surprising benefit - it might be able to shrink certain tumors
The COVID-19 virus may come with a surprising benefit. It may have the ability to shrink certain cancerous tumors, according to a new study.
Femsa Sharpens Focus on Beverage, Retail, and Digital Platform to Ride Consumption Tailwinds
We award a narrow economic moat rating to Femsa based on the intangible assets and cost advantages at major subsidiaries Coca-Cola Femsa and the Oxxo small-format retail chain, which jointly make up ...
Morningstar16h
Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation
Merck & Co. Inc.'s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck (MRK) said a trial of the drug, given ...
Scor's Underwriting Quality Has Been Lacking but It's Improving Expenses and Underwriting Discipline
Scor operates with a dividend policy that is least equal to the dividend paid in the prior year. This is subject to solvency within the 185%-220% target. The dividend can be complemented with share ...
The market looks strong and Wall Street is wrong about that 'lost decade' for stocks
In the late 1960s and early 1970s, the so-called Nifty Fifty stocks led big gains for the U.S. market, but ultimately the 1970s was a lost decade for stocks. The late1990s tech boom, led by Microsoft ...
Aecom Is Poised to Capitalize on Growing Infrastructure Spending
Furthermore, Aecom has improved its profitability thanks to several recent initiatives, including a $225 million general and administrative cost-reduction plan completed in fiscal 2019, real estate ...